Daniëlle Krooshoop

Daniëlle studied Biomedical Health Sciences. She has a PhD in Medical Sciences from the University of Nijmegen. After conducting research as a postdoc at Utrecht University, she started working for a large innovator company. She has extensive experience in Pharmacovigilance and Medical Affairs. In 2021, she joined DADA as Consultant Pharmacovigilance. As a member of the Benefit Risk Management team, she is primarily involved in signal management, risk management and writing of periodic safety reports.